The Nile Blue Sulfate (NBS) test is a cytological staining test performed on amniotic fluid to estimate fetal maturity based on the lipid content of shed fetal cells. It was first described by Brosens & Gordon (1966) and was widely used before modern biochemical tests (L/S ratio, PG) became available.
As the fetus matures, sebaceous glands in the skin begin secreting neutral lipids. These lipid-laden, anucleate squamous cells shed into the amniotic fluid and stain orange with Nile Blue Sulfate.
Henry's Clinical Diagnosis and Management by Laboratory Methods confirms the >50% stained fraction corresponds to term gestation.
The 0.1% Nile Blue test is a simple, historical bedside test using
amniotic fluid where
>50% orange-staining anucleate cells indicates fetal maturity (approximately ≥38-40 weeks). It is primarily of historical/academic interest today, having been superseded by biochemical tests like the
L/S ratio.